Your browser doesn't support javascript.
loading
Gemcitabine and docetaxel versus doxorubicin as first-line treatment in previously untreated advanced unresectable or metastatic soft-tissue sarcomas (GeDDiS): a randomised controlled phase 3 trial.
Seddon, Beatrice; Strauss, Sandra J; Whelan, Jeremy; Leahy, Michael; Woll, Penella J; Cowie, Fiona; Rothermundt, Christian; Wood, Zoe; Benson, Charlotte; Ali, Nasim; Marples, Maria; Veal, Gareth J; Jamieson, David; Küver, Katja; Tirabosco, Roberto; Forsyth, Sharon; Nash, Stephen; Dehbi, Hakim-Moulay; Beare, Sandy.
Afiliação
  • Seddon B; University College London Hospitals NHS Foundation Trust, London, UK. Electronic address: beatrice.seddon@uclh.nhs.uk.
  • Strauss SJ; University College London Hospitals NHS Foundation Trust, London, UK; UCL Cancer Institute, London, UK.
  • Whelan J; University College London Hospitals NHS Foundation Trust, London, UK.
  • Leahy M; The Christie NHS Foundation Trust, Manchester, UK.
  • Woll PJ; University of Sheffield, Sheffield, UK.
  • Cowie F; Beatson West of Scotland Cancer Centre, Glasgow, UK.
  • Rothermundt C; Kantonsspital, St Gallen, Switzerland; Swiss Group for Clinical Cancer Research (SAKK), Bern, Switzerland.
  • Wood Z; University College London Hospitals NHS Foundation Trust, London, UK.
  • Benson C; The Royal Marsden NHS Foundation Trust, London, UK.
  • Ali N; The Clatterbridge Cancer Centre NHS Foundation Trust, Wirral, UK.
  • Marples M; The Leeds Teaching Hospitals NHS Trust, Leeds, UK.
  • Veal GJ; Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne, UK.
  • Jamieson D; Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne, UK.
  • Küver K; Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne, UK.
  • Tirabosco R; Royal National Orthopaedic Hospital, Stanmore, UK.
  • Forsyth S; Cancer Research UK and UCL Cancer Trials Centre, London, UK.
  • Nash S; Cancer Research UK and UCL Cancer Trials Centre, London, UK.
  • Dehbi HM; Cancer Research UK and UCL Cancer Trials Centre, London, UK.
  • Beare S; Cancer Research UK and UCL Cancer Trials Centre, London, UK.
Lancet Oncol ; 18(10): 1397-1410, 2017 10.
Article em En | MEDLINE | ID: mdl-28882536
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Sarcoma / Neoplasias de Tecidos Moles / Protocolos de Quimioterapia Combinada Antineoplásica País/Região como assunto: Europa Idioma: En Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Sarcoma / Neoplasias de Tecidos Moles / Protocolos de Quimioterapia Combinada Antineoplásica País/Região como assunto: Europa Idioma: En Ano de publicação: 2017 Tipo de documento: Article